US Patent 8642752 Modulation of Hepatitis B virus (HBV) expression
Patent 8642752 was granted and assigned to Ionis Pharmaceuticals on February, 2014 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8642752 Modulation of Hepatitis B virus (HBV) expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.